Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI.
Sundaresan VM, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert TM, Loeb S, Cooperberg MR, Catalona WJ, Sprenkle PC, Kim IY, Leapman MS.
Sundaresan VM, et al. Among authors: sutherland r.
Urol Oncol. 2024 Dec 19:S1078-1439(24)00723-3. doi: 10.1016/j.urolonc.2024.11.007. Online ahead of print.
Urol Oncol. 2024.
PMID: 39706698